Abstract Pioglitazone, an insulin-sensitizing, antidiabetic agent, has blood pressure-lowering effects in insulin-resistant hypertensive rats and attenuates growth factor-induced increases of intracellular Ca 2+ in rat aortic vascular smooth muscle cells. To determine whether modulation of voltagedependent Ca 2+ channels plays a role in this association, we investigated the effects of pioglitazone on voltage-dependent current in cultured rat aortic (a7r5) and freshly dissociated rat tail artery vascular smooth muscle cells. Both cell types were studied with whole-cell patch-clamp techniques. Current through L-type Ca 2+ channels was elicited with a voltage ramp in the presence of Ba 2+ substituted for Ca 2+ . T-type Ca 2+ current was studied using a two-pulse protocol that enabled the isolation of transient current. In a7r5 vascular smooth muscle cells, 2-minute application of pioglitazone (5 and 10 /imol/L) reduced L-type current by 7.9±1.0% (n=8)
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Abstract Pioglitazone, an insulin-sensitizing, antidiabetic agent, has blood pressure-lowering effects in insulin-resistant hypertensive rats and attenuates growth factor-induced increases of intracellular Ca 2+ in rat aortic vascular smooth muscle cells. To determine whether modulation of voltagedependent Ca 2+ channels plays a role in this association, we investigated the effects of pioglitazone on voltage-dependent current in cultured rat aortic (a7r5) and freshly dissociated rat tail artery vascular smooth muscle cells. Both cell types were studied with whole-cell patch-clamp techniques. Current through L-type Ca 2+ channels was elicited with a voltage ramp in the presence of Ba 2+ substituted for Ca 2+ . T-type Ca 2+ current was studied using a two-pulse protocol that enabled the isolation of transient current. In a7r5 vascular smooth muscle cells, 2-minute application of pioglitazone (5 and 10 /imol/L) reduced L-type current by 7.9±1.0% (n=8) T here is increasing evidence that insulin resistance exists in various genetic models of hypertension, such as Dahl salt-sensitive, Zucker obese, and spontaneously hypertensive rats. 15 Several mechanisms have been proposed to explain this association, including resistance to a direct vasodilator effect of insulin. 5 Recent work suggests that insulin may affect vascular tone through direct effects on the regulation of vascular smooth muscle cell (VSMC) intracellular calcium ([Ca 2+ ]i). 57 Insulin attenuates vasopressin- 6 and angiotensin-stimulated 7 VSMC [Ca 2+ ], transients, reduces transmembrane inward Ca 2+ current, 6 and shifts the voltage dependence of Ca 2+ current to the right. 6 Since [Ca 2+ ]i plays a major role in regulating vascular tone, the vasodepressor effects of insulin may be mediated through its effects on VSMC [Ca 2+ ]i.
Recently, two classes of antidiabetic, insulin-sensitizing agents (biguanides and thiazolidinediones) were reported to lower blood pressure in genetic models of hypertension. 810 Unlike sulfonylureas, which inhibit K + channels, stimulate insulin secretion, and increase blood pressure, the thiazolidinediones are a novel group of compounds that increase the sensitivity of target tissues to insulin-stimulated glucose uptake without (mean±SEM, number of cells) and 14.5±3.0% (n=9) (P<.01, two-tailed paired t test), respectively. In contrast, 2-minute application of pioglitazone had no significant effect on T-type Ca 2+ current. In freshly dissociated tail artery vascular smooth muscle cells, 2-minute application of 10 /imol/L pioglitazone had an insignificant effect (4.8±5.6% reduction); however, 25 fimolfL pioglitazone reduced L-type current by 27.3 ±7.2% (n=5) (P<.01). Two-minute application of 0.1% or 0.2% dimethyl sulfoxide (vehicle) alone had no significant effects on currents in either type of vascular smooth muscle cell. The blood pressure-lowering and growth-inhibiting effects of pioglitazone may be in part due to inhibition of inward Ca 1113 However, the mechanisms by which these compounds lower blood pressure are currently unknown.
Recent observations 6 -8 ' 9 ' 13 suggested to us a possible mechanism by which these agents might affect vascular tone. First, these compounds appear to increase insulin sensitivity by exerting postbinding effects on facilitated glucose uptake. 13 Second, glucose uptake can be modulated by insulin in VSMCs, 14 These studies used a VSMC cell line (a7r5) and freshly dispersed rat tail artery VSMCs. A7r5 cells have previously been shown to respond to insulin, vasopressin, and other agents. 616 Furthermore, ionic currents elicited by vasopressin and depolarization are readily recorded in a7r5 cells. 6 ' 16 Rat tail artery has also been used in previous vascular smooth muscle studies, and contractile responses of tail artery VSMCs in primary culture are reduced by insulin.
Maintenance of the cell line has been previously described. 6 Cells were maintained in growth medium (Dulbecco's modified Eagle medium supplemented with 9% fetal bovine serum, 0.2% Tylosin, 100 U/tnL penicillin, and 0.1 mg/mL streptomycin) and placed in a 37°C water-jacketed incubator under 5% CO 2 4. Blood clots, fat, and connective tissue were removed. After several rinses with PSS, the tail artery was cut longitudinally, and endothelium was removed with a sterile swab. The artery was cut many times (0.5-mm interval) at the edges and then incubated in digestion solution for 45 to 60 minutes at 37°C in a water bath incubator. Digestion solution was freshly made Hanks' solution (10 mL) supplemented with 5 mg collagenase, 3.5 mg papain, and 6 mg dithiothreitol. Freshly made Hanks' solution contained (mmol/L) NaCl 140, KC1 5.4, NaHCO 3 4.17, KH 2 PO 4 0.44, NaH 2 PO 4 0.42, dextrose 5.5, CaCl 2 0.1, and HEPES 5.0, with pH 7.4. After the digestion, tissue was transferred to a small Petri dish containing Hanks' solution and gently rinsed several times. Cells were then released by triturating the tissue gently with a glass transfer pipette. Cells were refrigerated in Hanks' solution at 4°C for several hours to 1 day before patch clamping.
Whole-Cell Patch Clamp
Confluent a7r5 cells were replated onto 35x10-mm Petri dishes and incubated for 2 hours under 5% CO 2 and 100% humidity at 37°C in growth medium. Before recording, a plastic ring was inserted into the dish, forming a subchamber approximately 0.4 mL in volume. Cells were superfused with extracellular medium at room temperature (approximately 23°C) at 3 mL/min. Whole-cell voltage-clamp experiments were performed with an Axopatch 200 patch-clamp amplifier (Axon Instruments Inc) controlled by a Labmaster TL-1 DMA A/D digital-to-analog interface using the pClamp (Axon Instruments) suite of programs. 6 For study of the effect of pioglitazone on L-type Ca 2+ channels, the extracellular medium contained (mmol/L) BaCl 2 20, NaCl 113, KC1 4, MgCl 2 2, and HEPES 10, pH 7.4, and the electrode solution contained (mmol/L) CsCl 120, Cs-EGTA 10, MgCl 2 1.4, Mg-ATP 3.6, Na-GTP 1, and HEPES 10, pH 7.2. The current was elicited by a ramp protocol with a holding potential of -80 mV and a ramp going from -100 to 50 mV in 300 milliseconds with a digital resolution of 1 mV. Linear leakage and holding current were removed from the entire current response by subtracting the linear current trend and average holding current between -80 and -60 mV. The response to the voltage ramp protocol from -80 to 50 mV was analyzed.
For study of the effect of pioglitazone on T-type Ca 2+ channels, the extracellular medium was the same except that Ca 2+ was substituted for Ba 2+ ; the electrode solution remained unchanged. T-type Ca 2+ current was analyzed using a twopulse voltage protocol. The initial holding potential was -80 mV. The first pulse depolarized the cell from -80 to -15 mV for 75 milliseconds and then repolarized the cell to -30 mV. After 150 milliseconds at -30 mV, the cell was depolarized again to -15 mV for 75 milliseconds and then repolarized to -80 mV. Linear leakage was removed automatically by the pClamp CLAMPEX program during data acquisition. The current elicited by the second pulse was subtracted from the first pulse, and the difference between the two pulses is T-type current.
Pioglitazone was dissolved in dimethyl sulfoxide (DMSO) and later diluted for use in extracellular medium. Control medium was the extracellular medium containing the same final concentration of DMSO as the pioglitazone solutions. In experiments with a7r5 cells, pioglitazone concentrations were 5 and 10 fimolfL with corresponding DMSO concentrations of 0.1% and 0.2% in volume, respectively. In experiments with tail artery VSMCs, pioglitazone concentrations were 10 and 25 /xmol/L with corresponding DMSO concentrations of 0.04% and 0.1%, respectively. Protocols for either T-or L-type channels were run throughout the experiments at 20-second intervals. Currents were elicited under control conditions for 2 minutes before application of pioglitazone. Pioglitazone was perfused constantly for 2 minutes and then washed out with control medium.
Statistical comparisons used paired and unpaired t tests, with the criterion for significance adjusted by the Bonferroni correction for number of preplanned comparisons. In all cases, a value of P<.01 was therefore more than sufficient to achieve statistical significance. In the preplanned comparison of the effect of two pioglitazone concentrations (as in Figs 3 and 6) , the criterion for significance was F<.05.
Results
Two types of inward currents were observed in a7r5 cells when cells were depolarized from -80 to 50 mV with the ramp protocol ( Fig 1A) . As described in our previous work, 16 the first component of the current corresponds to T-type current, and the second component corresponds to L-type current. Previous studies have shown that current through L-type Ca 2+ channels is enhanced by Ba 2+ , whereas current through T-type Ca 2+ channels is reduced (Fig 1A) . 16 ' 18 Although the Tand L-type currents overlap each other, T-type current does not affect the peak L-type current. 16 In preliminary experiments to determine the optimal pulse potential to elicit peak T-type current with minimal L-type contamination, currents were elicited by pulses from -80 mV to various potentials with a 10-mV step ( Fig  IB) . Peak transient current was elicited by depolarization to -11.25±2.2 mV (n=24 cells). At -20 mV, the current averaged 88.1 ±3.5% (n=24) of the peak current. Therefore -15 mV was chosen as the voltage at which to analyze effects on peak T-type current. In response to the pulse protocol used to study T-type current, a transient current was observed when the cell was depolarized from -80 to -15 mV by the first pulse, and it inactivated within 75 milliseconds (Fig 1C) . After an additional 150 milliseconds at -30 mV, in most cases very little current was elicited by a second pulse to -15 mV. Regardless, any non-inactivating current present in the responses was removed by the subtraction protocol, leaving isolated T-type current. These currents were mediated by Ca 2+ channels: K + current was blocked by tetraethylammonium in the medium and Cs + in the electrode, and both T-and L-type currents were abolished in extracellular solution containing neither Ba 2+ nor Ca 2+ (Fig 1) . Similarly, both T-and L-type currents were observed in freshly dissociated rat tail artery VSMCs (see below) and were also abolished in 0 mmol/L Ca 2+ /Ba 2+ solution. T-type current was not analyzed in tail artery cells because T-type current was usually very small in these cells. Pioglitazone reduced L-type current in both a7r5 and rat tail artery VSMCs. Fig 2 shows the time course of pioglitazone and DMSO effects in a typical a7r5 cell. Two-minute application of 5 /nmol/L pioglitazone significantly reduced peak L-type current by 7.9±1.0% (n=8) (mean±SEM, number of cells) below the immediately preceding current measured in 0.1% DMSO (P<.01, two-tailed paired t test). During 2-minute application of 0.1% DMSO alone, no significant change (-0.6±1.0%, n=7)in L-type current occurred (P>J5). Correspondingly, 10 /xmol/L pioglitazone significantly reduced peak L-type current by 14.5±3.0% (n=9) (P<.0l), whereas 0.2% DMSO alone had no significant effect (2.4±1.6%, n=7, P>.18). The effects of 5 and 10 fimolfL pioglitazone, compared with the effects of 0.1% and 0.2% DMSO, respectively, were significant (P<.01, two-tailed unpaired t test). Pioglitazone at 10 ^tmol/L had a greater inhibitory effect on L-type current than at 5 /Amol/L (/ > <.01 > two-tailed unpaired / test). In contrast, pioglitazone had no significant effect on T-type current in a7r5 cells. Fig 4 shows the results of a typical experiment. Applications of 10 jtmol/L pioglitazone and 0.1% DMSO did not significantly reduce peak T-type current (5.6±2.5%, n=9 and 3.6±2.0%, n=9, respectively, P>.\, paired t test).
Freshly dispersed tail artery VSMCs were spindle shaped and approximately 5 ^m in diameter by 50 iim long. This was much smaller than a7r5 cells, which were approximately 40x150 fim. Correspondingly, the peak L-type Ca 2+ current in tail artery VSMCs was only 39.3±6.5 pA (n=7), which was much smaller than the peak L-type Ca 2+ current in a7r5 cells, which averaged 1265±89 pA (n=86) (data from previous experiments). Tail artery VSMCs contracted in response to depolarization and application of 10" 7 mol/L vasopressin. Similar results were obtained from tail artery VSMCs with the same protocol as in experiments on L-type current in a7r5 cells. Fig 5 shows the time course of pioglitazone effects and representative L-type currents in a typical tail artery VSMC. Fig 6 summarizes the results of several experiments. Application of 25 ^mol/L pioglitazone for 2 minutes significantly reduced peak L-type current by 27.3±7.2% (n=5) below the immediately preceding current measured in 0.1% DMSO (P<.01, two-tailed paired t test). However, 10 ^imol/L pioglitazone did not significantly reduce peak L-type current (4.8±5.6%, n=4). Application of 0.04% and 0.1% DMSO alone had no significant effect on L-type current (4.4±4.9% reduction, n=4 and 4.7±5.1% reduction, n=5, respectively). The effect of 25 ^mol/L pioglitazone, compared with the effects of 10 ^mol/L pioglita- zone and 0.1% DMSO, was significant (P<.05, twotailed unpaired t test).
Discussion
These results show that the insulin-sensitizing compound pioglitazone significantly attenuates inward current through voltage-dependent Ca 2+ channels in rat VSMCs in both an embryonic cell line and freshly dissociated tail artery cells. Furthermore, our data indicate that the effects of pioglitazone appear to be explained by action on L-type Ca 2+ channels. The ramp protocol we have used is appropriate for identifying the affected current as an L-type current, because the current activates in the appropriate voltage range, is selectively inhibited by isradipine, 16 and activates fully but does not inactivate within the duration of the ramp (unpublished data, 1993). However, ramp protocols to study the L-type current preclude any speculation as to mechanism, eg, a voltage-dependent channel block that causes inactivation during the ramp versus a simple block of the channel. Tail current analysis would be necessary to quantify accurately the voltage dependence of the affected current.
Because of the important role of [Ca 2+ ], in the maintenance of vascular tone, inhibition of Ca 2+ influx through voltage-dependent channels by pioglitazone is likely to be one mechanism by which this compound exerts its blood pressure-lowering effects in genetic models of hypertension. 89 In long-term in vitro experiments, we 19 27 Recent observations also suggest that insulin increased glucose transport in VSMCs.
14 Thus, our observations that pioglitazone decreases VSMC voltage-mediated Ca 2+ influx and prior observations that pioglitazone increases glucose transport in other tissues 13 suggest that it has some of the same fundamental actions as insulin.
Sustained elevated levels of [Ca 2+ ], in insulin-sensitive cells may render these cells relatively resistant to insulin-mediated glucose transport. 2934 ], overload, ie, insulin-resistant conditions, result in improved insulin sensitivity and decreased vascular contractility. Although we cannot relate in vivo concentrations of pioglitazone directly to our in vitro experiments, it is possible that this drug may have similar effects in vivo. The observations that a drug that both reduces blood pressure and increases insulin sensitivity has significant inhibitory effects on VSMC Ca 2+ channel function suggest that altered VSMC [Ca 2+ ], metabolism may be a fundamental abnormality linking hypertension and insulin resistance. 35 
